Microbiome Therapeutics
Broomfield
About Microbiome Therapeutics
MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight. MicroBiome Therapeutics was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $3.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2017)
- Website: mbiome.com
- Phone: 212-584-2276
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/microbiome-therapeutics-156319 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.